It is a pharma private limited company based in Bareilly, Uttar Pradesh, India, established in 2014.
2014 | Bareilly, Uttar Pradesh, India | ActiveJagota Pharma & Sons Private Limited, a active private limited company, was established on 12 June 2014 in Bareilly, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900UP2014PTC064316. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹4.00 M.
It upholds a compliant status. Its leadership includes Rakesh Bhandari (Director), Aanchal Jauhri (Additional Director), Minisha Bass (Director). Past directors included Jitendra Pal Singh, Naveen Kumar. It holds ₹2.00 Cr open charges and ₹1.25 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ist Floor Kashish Complex Shastri Market, Bareilly, Uttar Pradesh, 243001.
U74900UP2014PTC064316
064316
12 June 2014
₹4.00 M
₹4.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Jagota Pharma & Sons Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Bhandari | Director | 12 Jun 2014 | Current |
| Aanchal Jauhri | Additional Director | 30 Nov 2024 | Current |
| Minisha Bass | Director | 12 Jun 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jan 2019 | Past |
| Pramod Abcsdd | Director | 10 Nov 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jagota Pharma & Sons Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.43% decrease. The company also saw a slight improvement in profitability, with a 2.39% increase in profit. The company's net worth moved up by a moderate rise of 5.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Jagota Pharma & Sons had a public holding of 30.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹12,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2017 | Others | ₹2.00 Cr | Open |
| 07 May 2015 | Punjab And Sind Bank | ₹1.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Jagota Pharma & Sons, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Jagota Pharma & Sons, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagota Pharma & Sons's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aanchal Jauhri was appointed as a Additional Director was appointed as a Additional Director on 30 Nov 2024 & has been associated with this company since 1 year 17 days . was completed.
The activity Jagota Pharma & Sons Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge with Others of Rs. 20.00 M registered on 28 Aug 2017 with Charge ID 100131632 was modified on 20 May 2024. was completed.
Progress on Jagota Pharma & Sons Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity A charge registered on 07 May 2015 via Charge ID 10572235 with Punjab And Sind Bank was fully satisfied on 04 Oct 2017. was completed.
A charge with Others amounted to Rs. 20.00 M with Charge ID 100131632 was registered on 28 Aug 2017. was recorded as a recent event.
The CIN of Jagota Pharma & Sons Private Limited is U74900UP2014PTC064316.
Jagota Pharma & Sons Private Limited is headquartered at Ist Floor Kashish Complex Shastri Market, Bareilly, Uttar Pradesh, 243001.
Jagota Pharma & Sons Private Limited was incorporated on 12 June 2014.
The current directors of Jagota Pharma & Sons Private Limited are
The primary industry of Jagota Pharma & Sons Private Limited is Trade.
Jagota Pharma & Sons Private Limited is unlisted.
The authorized capital of Jagota Pharma & Sons Private Limited is ₹4.00 M, and the paid-up capital is ₹4.00 M.
The compliance status of Jagota Pharma & Sons Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX